Suraksha Diagnostic IPO: Share Allotment Likely Today, GMP Hints Muted Listing; How To Check Status?

The allotment of shares for the Suraksha Diagnostic IPO is set to be finalised today, December 4. Suraksha Diagnostic, an integrated diagnostic chain, opened its IPO for subscription on November 29 and concluded it on December 3. The IPO received a moderate response from various investor categories, achieving an overall subscription rate of 1.27 times by the final bidding day.

Subscription Insight

The IPO saw notable interest from qualified institutional buyers (QIBs), who subscribed to the issue 1.74 times their reserved portion. Non-institutional investors (NIIs) followed with a subscription rate of 1.41 times. Meanwhile, retail investors subscribed to 95% of their allocated portion.

Important Dates for Investors

Investors awaiting the allotment results can check their share allocation status today. For those who did not receive shares, refunds will be initiated on December 5. Successful applicants will have the allocated shares credited to their demat accounts on the same day. The shares are set to list on the stock exchanges on December 6, which will determine the market's reaction to the IPO and set the tone for its trading debut.

How to Check IPO Allotment Status

Investors can check the Suraksha Diagnostic IPO allotment status through multiple platforms:

Kfin Technologies Ltd

Visit the IPO status link: Kfintech IPO Status.
Choose "Suraksha Diagnostic IPO" from the dropdown menu.
Enter your PAN, application number, or demat account details along with the captcha code.
Click "Submit" to view your allotment status.

BSE Website:

Go to the BSE Allotment Page.
Under "Issue Type," select "Equity".
Choose "Suraksha Diagnostic IPO" from the dropdown.
Enter your PAN or application number to check your status.

NSE Website:

Visit the NSE IPO Allotment Page.
Register using your PAN if you are a new user.
Log in and follow the steps to access your allotment details.

Grey Market Performance

As of today, the grey market premium (GMP) for the Suraksha Diagnostic IPO stands at Rs 2, indicating a modest demand above the issue price. With the IPO price band set at Rs 441, the estimated listing price is projected to be Rs 443, reflecting a marginal 0.45% premium.

Experts note that the GMP has fluctuated between Rs 0 and Rs 2 over the last 10 sessions, with an upward trend observed in recent days. While the GMP provides an early indication of investor sentiment, actual listing performance will hinge on broader market conditions and company fundamentals.

Grey market premium represents the extra amount investors are willing to pay over the IPO price, showcasing market anticipation ahead of the official listing. The modest GMP for Suraksha Diagnostic suggests cautious optimism, with the possibility of a steady listing.

The healthcare diagnostics sector has been gaining traction among investors due to rising demand for diagnostic services and increasing awareness about preventive healthcare. Suraksha Diagnostic's IPO reflects the growing interest in companies that cater to this evolving market. However, the muted retail subscription and modest GMP indicate that investors are adopting a measured approach.